Tissue engineering with transplanted cells has the potential to repair and regenerate almost every tissue and organ of the body. One major obstacle of cell therapies is the inability to longitudinally assess injected cells. Non-invasive imaging with contrast-enhanced MRI is highly suited for this task but is limited with current methods. In this study, we report a novel method for producing bright endogenous cellular contrast through a genetic MRI reporter that results in the formation of in situ ferritin-manganese nanoparticles. The signal produced by these cells is significantly higher than traditional iron labelled ferritin-overexpressing cells and manganese-permeable cell lines.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords